Semaglutide News

Novo may have muscle advantage over Lilly in weight-loss race: preprint - BioSpace

Novo may have muscle advantage over Lilly in weight-loss race: preprint BioSpace

China to drive a weight-loss drug price war - Financial Times

China to drive a weight-loss drug price war Financial Times

Ozempic just got cheap enough to change the world - vox.com

Ozempic just got cheap enough to change the world vox.com

Semaglutide May Reverse Damage Caused by Osteoarthritis, Study Suggests - ScienceAlert

Semaglutide May Reverse Damage Caused by Osteoarthritis, Study Suggests ScienceAlert

Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials - The Lancet

Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials The Lancet

India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top - CNBC

India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top CNBC

Ozempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight - BBC

Ozempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight BBC

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds - The Guardian

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds The Guardian

With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics - Fierce Pharma

With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics Fierce Pharma

Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy - Reuters

Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy Reuters

Clinical trial results show weight loss drug reduces the risk of heart and liver diseases in people with obesity - VCU Health

Clinical trial results show weight loss drug reduces the risk of heart and liver diseases in people with obesity VCU Health

GLP-1 medicine improves liver health independent of weight loss, study finds - Medical Xpress

GLP-1 medicine improves liver health independent of weight loss, study finds Medical Xpress

Health news round-up: semaglutide and liver health, obesity vaccine response and hope for pancreatic cancer - The Pharmaceutical Journal

Health news round-up: semaglutide and liver health, obesity vaccine response and hope for pancreatic cancer The Pharmaceutical Journal

Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds - Reuters

Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds Reuters

Tirzepatide and semaglutide: Experts explain new diabetes, obesity drug options - MSN

Tirzepatide and semaglutide: Experts explain new diabetes, obesity drug options MSN

Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial - Nature

Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial Nature

Tirzepatide linked to more lean mass loss than semaglutide - European Medical Journal

Tirzepatide linked to more lean mass loss than semaglutide European Medical Journal

Comparison of Oral Semaglutide (Wegovy) and Orforglipron (Foundayo) for the Treatment of Obesity and Overweight - Medical Professionals Reference

Comparison of Oral Semaglutide (Wegovy) and Orforglipron (Foundayo) for the Treatment of Obesity and Overweight Medical Professionals Reference

Single-dose 7.2mg semaglutide (Wegovy) pen approved to treat adult patients with obesity - GOV.UK

Single-dose 7.2mg semaglutide (Wegovy) pen approved to treat adult patients with obesity GOV.UK

Canadian lab explains puzzling link between semaglutide, better liver health - The Globe and Mail

Canadian lab explains puzzling link between semaglutide, better liver health The Globe and Mail

Semaglutide is going off-patent in India. But will people who need it be able to get it? - statnews.com

Semaglutide is going off-patent in India. But will people who need it be able to get it? statnews.com

Oral Semaglutide Pills for Weight Management: What to Know - Cedars-Sinai

Oral Semaglutide Pills for Weight Management: What to Know Cedars-Sinai

Semaglutide Improves Knee Replacements for Patients with Diabetes - Yale School of Medicine

Semaglutide Improves Knee Replacements for Patients with Diabetes Yale School of Medicine

GLP-1 Drug Improves Liver Health Independent of Weight Loss, Mouse Study Finds - Genetic Engineering and Biotechnology News

GLP-1 Drug Improves Liver Health Independent of Weight Loss, Mouse Study Finds Genetic Engineering and Biotechnology News

Ozempic Is About to Go Generic for Billions of People - The New York Times

Ozempic Is About to Go Generic for Billions of People The New York Times

Genetic predictors of GLP1 receptor agonist weight loss and side effects - Nature

Genetic predictors of GLP1 receptor agonist weight loss and side effects Nature

The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs - Nature

The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs Nature

Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial - Nature

Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial Nature

Oral semaglutide lowers risk of heart failure events in people with Type 2 diabetes - OHSU News

Oral semaglutide lowers risk of heart failure events in people with Type 2 diabetes OHSU News

MSN Launches 50% Lower-Cost Semaglutide Pen ‘Semabest’ in India - NAVLIN DAILY

MSN Launches 50% Lower-Cost Semaglutide Pen ‘Semabest’ in India NAVLIN DAILY

Wegovy vs. Compounded Semaglutide for Weight Loss: 5 Differences to Consider - GoodRx

Wegovy vs. Compounded Semaglutide for Weight Loss: 5 Differences to Consider GoodRx

Higher dose of semaglutide increases weight loss, metabolic benefits: Newsroom - UT Southwestern Medical Center

Higher dose of semaglutide increases weight loss, metabolic benefits: Newsroom UT Southwestern Medical Center

Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison | International Journal of Obesity - Nature

Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison | International Journal of Obesity Nature